Waters Corporation (WAT) Key Metrics

NYSE: WATValuation, returns, debt and efficiency ratios over 10 years.

WAT valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$42.90B
Enterprise value
$46.21B
P/E (TTM)
110.6
10-yr median 30.0
Forward P/E
24.8
PEG ratio
1.57
Price / sales
9.2
10-yr median 6.7
Price / book
2.7
10-yr median 12.1
EV / EBITDA
47.8
10-yr median 22.1
Dividend yield
—
Beta
1.15

WAT key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

WAT valuation Price multiples at each fiscal year-end price.

P/E ratio+1.9%
35.3
2025 · hover or tap a bar for each year
2016: 21.0 (−12.0%)2017: 766.7 (+3,554.1%)2018: 24.7 (−96.8%)2019: 26.9 (+9.1%)2020: 29.6 (+10.1%)2021: 33.4 (+12.7%)2022: 29.2 (−12.5%)2023: 30.4 (+4.0%)2024: 34.6 (+14.0%)2025: 35.3 (+1.9%)
20162025
Price / sales−4.1%
7.2
2025 · hover or tap a bar for each year
2016: 5.0 (−7.8%)2017: 6.7 (+33.6%)2018: 6.1 (−10.3%)2019: 6.6 (+9.4%)2020: 6.5 (−1.4%)2021: 8.3 (+27.1%)2022: 7.0 (−16.2%)2023: 6.6 (−5.1%)2024: 7.5 (+13.1%)2025: 7.2 (−4.1%)
20162025
Price / book−26.7%
8.9
2025 · hover or tap a bar for each year
2016: 4.8 (−12.5%)2017: 7.0 (+46.7%)2018: 9.3 (+34.0%)2020: 66.52021: 62.9 (−5.5%)2022: 41.0 (−34.8%)2023: 17.0 (−58.6%)2024: 12.1 (−28.8%)2025: 8.9 (−26.7%)
20162025
EV / EBITDA+2.9%
23.3
2025 · hover or tap a bar for each year
2016: 13.4 (−14.2%)2017: 17.6 (+31.3%)2018: 16.7 (−5.0%)2019: 22.7 (+35.2%)2020: 20.9 (−7.9%)2021: 24.5 (+17.5%)2022: 21.5 (−12.3%)2023: 26.4 (+22.7%)2024: 22.6 (−14.1%)2025: 23.3 (+2.9%)
20162025
Price / free cash flow+17.8%
42.0
2025 · hover or tap a bar for each year
2016: 20.5 (−16.2%)2017: 25.6 (+25.2%)2018: 30.7 (+19.7%)2019: 33.2 (+8.2%)2020: 25.0 (−24.8%)2021: 39.9 (+59.8%)2022: 48.3 (+20.9%)2023: 44.1 (−8.6%)2024: 35.7 (−19.2%)2025: 42.0 (+17.8%)
20162025
Free cash flow yield−0.4 pts
2.4%
2025 · hover or tap a bar for each year
2016: 4.9% (+0.8 pts)2017: 3.9% (−1.0 pts)2018: 3.3% (−0.6 pts)2019: 3.0% (−0.2 pts)2020: 4.0% (+1.0 pts)2021: 2.5% (−1.5 pts)2022: 2.1% (−0.4 pts)2023: 2.3% (+0.2 pts)2024: 2.8% (+0.5 pts)2025: 2.4% (−0.4 pts)
20162025

WAT valuation history

Fiscal year-endToday10-year median

WAT returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

WAT debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

WAT cash returned to shareholders

DividendsBuybacksFree cash flow

WAT price vs earnings per share

Share price at year-endEPS (right axis)

WAT key metrics

2016–2025
Waters Corporation key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$22.68B$22.09B$19.51B$20.67B$23.11B$15.44B$15.93B$14.64B$15.57B$10.94B
Enterprise value$23.58B$23.47B$21.56B$21.85B$24.08B$16.38B$18.85B$14.06B$14.18B$9.96B
P/E ratio35.334.630.429.233.429.626.924.7766.721.0
Price / sales7.27.56.67.08.36.56.66.16.75.0
Price / book8.912.117.041.062.966.5—9.37.04.8
Price / free cash flow42.035.744.148.339.925.033.230.725.620.5
Price / operating cash flow34.829.032.433.830.919.524.824.222.317.4
EV / sales7.57.97.37.48.66.97.85.86.14.6
EV / EBITDA23.322.626.421.524.520.922.716.717.613.4
EV / free cash flow43.737.948.851.041.626.539.329.523.318.6
Earnings yield2.8%2.9%3.3%3.4%3.0%3.4%3.7%4.1%0.1%4.8%
Free cash flow yield2.4%2.8%2.3%2.1%2.5%4.0%3.0%3.3%3.9%4.9%
Dividend yield——8.0%0.2%0.2%0.4%0.3%—0.0%0.0%
Shareholder yield (dividends + buybacks)0.1%0.1%8.4%3.2%3.0%1.7%15.8%9.0%2.1%3.0%
Share price at fiscal year-end$379.83$370.98$329.23$342.58$372.60$247.42$233.65$188.65$193.19$134.39
Per share
Revenue per share$53.01$49.68$49.88$49.26$44.91$37.90$35.30$31.18$28.65$26.62
Earnings per share$10.76$10.71$10.84$11.73$11.17$8.36$8.69$7.65$0.25$6.41
Operating cash flow per share$10.93$12.80$10.17$10.14$12.05$12.67$9.43$7.79$8.66$7.73
Free cash flow per share$9.04$10.41$7.46$7.10$9.33$9.90$7.03$6.14$7.53$6.56
Cash per share$9.85$5.46$6.68$7.98$9.18$7.10$4.95$22.36$42.10$34.55
Book value per share$42.90$30.70$19.41$8.36$5.93$3.72−$3.17$20.19$27.71$28.27
Tangible book value per share$11.10−$0.59−$13.23−$2.54−$5.04−$7.54−$11.92$12.43$20.42$21.41
Dividends per share——$26.31$0.71$0.90$1.06$0.79—$0.00$0.00
Capex per share$1.89$2.39$2.71$3.04$2.71$2.76$2.40$1.64$1.12$1.17
Debt per share$24.97$28.59$41.21$27.57$24.86$22.18$47.85$14.79$24.79$22.44
Shares outstanding59.7M59.6M59.3M60.3M62.0M62.4M68.2M77.6M80.6M81.4M
Change in shares outstanding+0.3%+0.5%−1.8%−2.7%−0.6%−8.4%−12.2%−3.7%−1.0%−2.0%
Returns & profitability
Return on equity (ROE)29.3%42.8%77.6%162.3%231.1%——31.2%0.9%23.9%
Return on invested capital (ROIC)22.8%21.8%29.2%48.8%56.2%28.4%33.5%70.8%30.7%41.1%
Return on assets (ROA)13.3%13.9%16.2%22.2%23.3%19.3%18.8%13.1%0.4%11.7%
Return on tangible assets20.2%23.7%23.9%27.0%28.7%24.4%30.2%19.0%0.4%12.7%
Free cash flow margin17.1%20.9%15.0%14.4%20.8%26.1%19.9%19.7%26.3%24.6%
Income quality (OCF / net income)1.021.190.940.861.081.521.091.0234.351.21
Financial health
Total debt$1.49B$1.70B$2.44B$1.66B$1.54B$1.38B$3.26B$1.15B$2.00B$1.83B
Cash & short-term investments$587.8M$325.4M$396.0M$481.4M$569.3M$443.1M$337.1M$1.74B$3.39B$2.81B
Net debt$903.3M$1.38B$2.05B$1.18B$972.5M$941.1M$2.92B−$586.9M−$1.40B−$985.8M
Debt / equity0.580.932.123.304.195.96—0.730.890.79
Debt / assets0.290.370.530.510.500.491.280.310.370.39
Net debt / EBITDA0.891.332.501.160.991.203.51−0.70−1.74−1.33
Current ratio1.732.112.222.242.261.640.745.937.046.99
Quick ratio1.271.511.571.661.741.260.555.286.606.48
Interest coverage12.89.29.917.918.313.214.615.211.713.9
Working capital$908.1M$879.4M$963.3M$978.2M$857.5M$515.8M−$435.7M$2.21B$3.66B$3.12B
Invested capital$3.46B$3.21B$3.20B$1.69B$1.34B$1.17B$2.71B$980.4M$837.9M$1.32B
Tangible asset value$663.0M−$35.1M−$784.3M−$153.2M−$312.7M−$470.9M−$812.6M$964.7M$1.65B$1.74B
Net current asset value−$367.7M−$1.06B−$1.72B−$1.01B−$1.19B−$1.29B−$1.53B$503.0M$1.16B$1.28B
Graham number$101.92$86.02$68.79$46.98$38.59$26.45—$58.95$12.53$63.83
Graham net-net per share−$17.08−$27.06−$38.73−$25.29−$24.51−$25.35−$26.92$1.89$10.22$11.68
Capital allocation
Dividends paid——$1.56B$42.8M$55.6M$66.0M$53.7M—$0$0
Share buybacks (net)$14.7M$13.5M$70.3M$626.1M$648.9M$196.4M$2.47B$1.32B$332.5M$325.8M
Dividend payout ratio——242.8%6.0%8.0%12.7%9.1%—0.0%0.0%
Dividends + buybacks / free cash flow2.7%2.2%368.5%156.2%121.7%42.5%526.4%275.8%54.8%61.0%
Capex / revenue3.6%4.8%5.4%6.2%6.0%7.3%6.8%5.3%3.9%4.4%
Capex / operating cash flow17.3%18.7%26.6%30.0%22.5%21.8%25.5%21.1%13.0%15.1%
Capex / depreciation0.550.740.971.411.281.381.561.180.850.98
Stock-based compensation / revenue1.7%1.5%1.2%1.4%1.1%1.6%1.6%1.6%1.7%1.9%
R&D / revenue6.2%6.2%5.9%5.9%6.0%6.0%5.9%5.9%5.7%5.8%
SG&A / revenue22.7%23.3%24.9%22.1%22.5%23.4%22.2%22.2%23.6%23.7%
Efficiency
Days sales outstanding90.188.688.082.077.789.687.783.180.980.6
Days of inventory on hand143.3151.1148.4118.7104.2113.3110.5103.3102.7107.7
Days payables outstanding27.828.127.227.826.722.021.224.425.528.3
Cash conversion cycle (days)205.6211.6209.2172.9155.2180.9177.0162.0158.1160.0
Receivables turnover4.054.124.154.454.704.074.164.394.514.53
Payables turnover13.1213.0013.4313.1313.6916.6117.2514.9614.3212.89
Inventory turnover2.552.422.463.083.503.223.303.533.553.39
Asset turnover0.660.640.750.930.940.880.770.530.460.49
Average receivables$781.1M$717.8M$712.5M$667.8M$593.0M$580.5M$578.0M$551.1M$511.6M$478.8M
Average payables$101.9M$92.3M$89.0M$95.1M$84.5M$60.6M$58.6M$66.4M$66.1M$69.2M
Average inventory$524.8M$496.7M$486.0M$405.9M$330.2M$312.4M$306.1M$280.9M$266.5M$263.0M
Intangibles / total assets37.4%40.9%41.8%20.0%22.0%24.8%23.3%16.2%11.0%12.0%

Computed from WAT's annual financial statements (latest annual report filed February 23, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

WAT valuation and financial ratios

At the end of fiscal 2025 (December 31, 2025), Waters traded at 35.3 times earnings, against a 10-year median of 30.0. Based on the latest twelve months, the trailing P/E is 110.6 and the forward P/E is 24.8. Waters earned a return on equity of 29.3% and a return on invested capital of 22.8% in fiscal 2025. It ended the year with $1.5 billion of debt and $587.8 million in cash and short-term investments, net debt of $903.3 million. It returned $14.7 million to shareholders: $0 in dividends and $14.7 million in share buybacks, 3% of free cash flow. The share count fell 26.7% from 81.4M to 59.7M over 9 years.

See the WAT income statement, the WAT chart for price history, or the WAT stock overview for the latest quote and news.

WAT key metrics FAQ

What is Waters's P/E ratio?

Waters's trailing P/E ratio is 110.6 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 24.8. At the end of fiscal 2025 it was 35.3, compared with a 10-year median of 30.0.

What is Waters's EV/EBITDA?

Waters's enterprise value was 23.3 times EBITDA at the end of fiscal 2025 (enterprise value $23.6 billion, EBITDA $1.0 billion); the current EV/EBITDA is 47.8.

What is Waters's return on equity?

Waters's return on equity (ROE) was 29.3% in fiscal 2025: net income of $642.6 million on average shareholders' equity of $2.2 billion.

What is Waters's ROIC?

Waters's return on invested capital was 22.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Waters have?

Waters had total debt of $1.5 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.58 and $903.3 million of net debt (0.89 times EBITDA).

Does Waters buy back its shares?

Yes. Waters spent $14.7 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.3% over the year, to 59.7M..

What is Waters's free cash flow yield?

Waters generated $539.8 million of free cash flow in fiscal 2025, a free cash flow yield of 2.4% on its market value at year-end ($22.7 billion).

What is Waters's current ratio?

Waters's current ratio was 1.73 at the end of fiscal 2025: current assets were 1.73 times current liabilities.

Diagnostics & Research key metrics